| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/18/2009 | EP2036547A2 Treatment for Attention-Deficit Hyperactivity Disorder |
| 03/18/2009 | EP2035369A1 Therapeutic compounds |
| 03/18/2009 | EP2035003A1 A method of reducing amyloid-beta peptide levels using a bisdioxopiperazine |
| 03/18/2009 | EP2034985A1 Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins |
| 03/18/2009 | EP2000137A9 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 03/18/2009 | EP1919477A4 Method of improving wakefulness |
| 03/18/2009 | EP1539927B1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2009 | EP1515745B1 Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 03/18/2009 | EP1513806B1 Sulphonic acid salts of mandelic acid derivatives |
| 03/18/2009 | EP1501846B1 Tricyclic macrolide antibacterial compounds |
| 03/18/2009 | EP1458720B1 1,8-annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
| 03/18/2009 | EP1453810B1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1386912B1 Cyclic amidine derivative |
| 03/18/2009 | EP1377273B1 Method for producing an isoflavone concentrate |
| 03/18/2009 | EP1353624B1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 03/18/2009 | EP1292294B1 Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease |
| 03/18/2009 | EP1095136B1 Cells and animals deficient in protein kinase c epsilon |
| 03/18/2009 | EP1068522B1 Helicobacter pylori nap protein |
| 03/18/2009 | EP1040094B1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors |
| 03/18/2009 | EP1030929B1 Transfection and transfer of non-human male germ cells for generation of transgenic non-human mammals |
| 03/18/2009 | EP0741783B1 Vertebrate embryonic pattern-inducing hedgehog-like proteins |
| 03/18/2009 | CN101389327A Singlet oxygen scavenger, anti-skin-aging agent, anti-wrinkle agent, anti-sagging agent, agent for improving moisture content in the skin, skin-whitening agent, melanin formation inhibitor, nitrogen m |
| 03/18/2009 | CN101389317A Controlled release solid preparation |
| 03/18/2009 | CN101386651A Expression and export of angiostatin and endostatin as immunofusis |
| 03/18/2009 | CN101386590A Pyrrolidone containing hydroxymethyl and carboxyl, preparation method and medicament composition and use thereof |
| 03/18/2009 | CN101385858A Purified PEG human growth hormone conjugates and preparation thereof |
| 03/18/2009 | CN101385738A Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/18/2009 | CN100469791C Glucagon-like peptide-1 analogs |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469778C Novel fused imidazole derivative |
| 03/18/2009 | CN100469386C Medicine composition for treating college entrance examination syndrome and its use |
| 03/17/2009 | USRE40667 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 03/17/2009 | US7504537 osteoarthritis or rheumatoid arthritis |
| 03/17/2009 | US7504507 carboxamide linked compounds based on benzo[b][1,6]naphthyridin-1 (2H)-one, which differ from previous acridine based compounds by the incorporation of a lactam or thiolactam function in one of the outer rings |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504432 Quaternary salt of (3-((2-(3,3-difluorocyclopentyl)-2-hydroxy-2-(4-methylphenyl)ethanoyl)oxy)-1,1-dimethylpyrrolidinium bromide; respiratory system disorders; chronic obstructive pulmonary diseases, bronchitis, asthma, emphysema, rhinitis; side effect reduction; inhalants; muscarinic receptor antagonists |
| 03/17/2009 | US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504416 4-substituted quinolines as antitumor agents |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504409 Chronic obstructive pulmonary disease; asthma; respiratory system disorders; administering 2-aminonicotinic acid, anthranilic acid, bendroflumethiazide |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504395 Treatment for attention-deficit hyperactivity disorder |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504257 Embryonic stem cells and neural progenitor cells derived therefrom |
| 03/17/2009 | US7504247 2-O sulfatase compositions and methods of degradation therewith |
| 03/17/2009 | US7504246 Hyaluronan synthase gene and uses thereof |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504096 Methods for in vitro fertilization |
| 03/17/2009 | CA2412594C Pyrazino[1',2':1,6]pyrido[3-4-5] indole derivatives |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2360668C The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2337849C Piperazinone derivatives and applications thereof |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2262546C Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation |
| 03/12/2009 | WO2009033027A2 Suppression of scn9a gene expression and/or function for the treatment of pain |
| 03/12/2009 | WO2009032888A2 Method for providing energy, relieving stress and mood enhancing benefits comprising administering a composition comprising cholecalciferol and a tea extract |
| 03/12/2009 | WO2009032885A2 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
| 03/12/2009 | WO2009032171A1 Subcutaneous administration of alpha-galatosidase a |
| 03/12/2009 | WO2009031709A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031708A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031706A1 Coumarin compound and use thereof |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031671A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 03/12/2009 | WO2009031627A1 Para-terphenyl compound or pharmacologically acceptable salt thereof, method for production of the same, and use of the same |
| 03/12/2009 | WO2009030093A1 Functions and uses of human protein phosphatase 1 inhibitor-2 |
| 03/12/2009 | WO2009030087A1 Functions and uses of phosphatidylethanolamine binding protein 4 |
| 03/12/2009 | WO2009029991A1 Agents with angiogenic and wound healing activity |
| 03/12/2009 | WO2008113557A3 Anti-infective agents |
| 03/12/2009 | US20090069565 New indole derivatives as factor xa inhibitors |
| 03/12/2009 | US20090069553 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 03/12/2009 | US20090069439 Use of pargyline for the treatment of hair folliclies |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090069424 TGF-alpha expression inhibitors |
| 03/12/2009 | US20090069375 Deuterium-enriched miglustat |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069334 Pyridazine based alpha-helix mimetics |
| 03/12/2009 | US20090069327 Compounds and compositions as protein kinase inhibitors |
| 03/12/2009 | US20090069325 Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity |
| 03/12/2009 | US20090069293 Succinoylamino benzodiazepines as inhibitors of ab protein production |
| 03/12/2009 | US20090069291 Salt Forms |
| 03/12/2009 | US20090069279 Invert emulsions containing dhea |
| 03/12/2009 | US20090069275 Low flush niacin formulation |
| 03/12/2009 | US20090069269 Oral composition containing difructose anhydride |
| 03/12/2009 | US20090069264 Toxoplasma gondii nucleic acid molecules |
| 03/12/2009 | US20090069260 Method for producing a nucleic-acid-containing complex preparation |
| 03/12/2009 | US20090069256 Enhancing protein expression |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090069243 Natriuretic activities |
| 03/12/2009 | US20090069238 Activatable clostridial toxins |
| 03/12/2009 | US20090069218 Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
| 03/12/2009 | US20090068291 Plant extracts and compositions comprising extracellular protease inhibitors |